tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ESALF Stock Latest News

Is ESALF a Buy, Before Earnings?
Pre-EarningsIs ESALF a Buy, Before Earnings?
9d ago
Eisai Co.’s Phase 1 Study of E7389-LF: Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Eisai Co.’s Phase 1 Study of E7389-LF: Potential Game-Changer in Cancer Treatment?
22d ago
ESALF
Eisai Co. Advances Cancer Treatment with E7389 Liposomal Study
PremiumCompany Announcements
Eisai Co. Advances Cancer Treatment with E7389 Liposomal Study
24d ago
ESALF
Eisai’s Lemborexant Study: A New Hope for Insomnia Treatment?
PremiumCompany Announcements
Eisai’s Lemborexant Study: A New Hope for Insomnia Treatment?
1M ago
ESALF
Eisai’s Fycompa Safety Study: A Potential Game-Changer in Epilepsy Treatment
PremiumCompany Announcements
Eisai’s Fycompa Safety Study: A Potential Game-Changer in Epilepsy Treatment
1M ago
ESALF
Eisai Co’s Strategic Initiatives and Growth Justify Buy Rating Despite Leqembi Guidance Concerns
PremiumRatingsEisai Co’s Strategic Initiatives and Growth Justify Buy Rating Despite Leqembi Guidance Concerns
3M ago
Eisai Co. Surpasses FY 2024 Expectations Amid Challenges
Premium
Company Announcements
Eisai Co. Surpasses FY 2024 Expectations Amid Challenges
3M ago
Eisai Co. Reports Cautious Optimism Amid Q3 Growth
Premium
Company Announcements
Eisai Co. Reports Cautious Optimism Amid Q3 Growth
6M ago
ESALF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ESALF Earnings this Week: How Will it Perform?
6M ago
Biogen (NASDAQ:BIIB) and Eisai Win FDA’s OK on Alzheimer’s Drug Dosing
PremiumMarket News
Biogen (NASDAQ:BIIB) and Eisai Win FDA’s OK on Alzheimer’s Drug Dosing
6M ago
BIIB
Eisai Co (ESALF) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Eisai Co (ESALF) Q2 Earnings Cheat Sheet
9M ago
Eli Lilly’s Alzheimer’s Drug Could be Rejected by NHS
PremiumMarket News
Eli Lilly’s Alzheimer’s Drug Could be Rejected by NHS
12M ago
LLY
BIIB
ESALF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsESALF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
Japanese Stocks: Eisai Shares Plummet as EU Rejects Alzheimer’s Drug
Premium
Global Markets
Japanese Stocks: Eisai Shares Plummet as EU Rejects Alzheimer’s Drug
1y ago
BIIB
Biogen (NASDAQ:BIIB) Ticks Up on New Alzheimer’s Drug in Japan
Premium
Market News
Biogen (NASDAQ:BIIB) Ticks Up on New Alzheimer’s Drug in Japan
2y ago
BIIB
Biogen, Eisai’s Alzheimer’s Drug Scores Big With FDA’s Full Approval
PremiumMarket News
Biogen, Eisai’s Alzheimer’s Drug Scores Big With FDA’s Full Approval
2y ago
BIIB
Eisai, Biogen say lecanemab received Priority Review status in Japan
PremiumThe Fly
Eisai, Biogen say lecanemab received Priority Review status in Japan
3y ago
BIIB
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
PremiumThe Fly
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
3y ago
BIIB
Catalyst Pharmaceuticals completes acquisition of U.S. rights to FYCOMPA CII
PremiumThe Fly
Catalyst Pharmaceuticals completes acquisition of U.S. rights to FYCOMPA CII
3y ago
CPRX
Biogen, Eisai May Have an Alzheimer’s Beater on Their Hands
PremiumMarket NewsBiogen, Eisai May Have an Alzheimer’s Beater on Their Hands
3y ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >